🔎 Trials Near Me

Home › Spinal Stenosis › NCT05504499

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

RecruitingHealthy volunteers welcome

REFINE Study: A Prospective, Observational, Open-Label, Non-Randomized, Multi-Center Study Measuring Functional Outcomes In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Subjects enrolled in this study must meet ALL of the following inclusion criteria:

  1. Subject must provide written informed consent prior to any clinical study-related procedure.
  2. Subject is at least 18 years or older at the time of enrollment, skeletal mature.
  3. Subject has 1-2 symptomatic lumbar degenerative disease at adjacent level, T12-S1, with or without grade I spondylolisthesis (confirmed by history and radiographic studies).
  4. MRI within 12 months prior to the procedure with at least mild to moderate spinal stenosis at the index treatment level
  5. Subject has undergone at least 3 months of non-operative treatment.
  6. Subject presents with ZCQ physical function ≥ 2.0 at baseline.
  7. Subject reports relief from lumbar flexion and/or sitting.
  8. Subject has baseline VAS of back and/or leg pain standing or walking ≥ 50mm.

Exclusion Criteria:

* Subjects enrolled in this study must NOT meet any of the following exclusion criteria:

  1. Subject is unable to provide written informed consent.
  2. Subject has had previous lumbar spine surgery at the intended treatment level (e.g., laminectomy or fusion).
  3. Subject has a grade II or greater spondylolisthesis on flexion and extension radiographs with 3mm instability.
  4. Subject has confirmed or suspected osteoporosis or osteopenia.
  5. Subject is enrolled, or intends to participate, in a clinical drug and/or device study (investigational device, investigational drug, new indication for a device or drug, or additional testing beyond standard of care procedures) which could confound the results of this trial as determined by the investigator.
  6. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements.
  7. Subject is pregnant or nursing.

About the study

The purpose of this study is to evaluate the effectiveness and safety of the use of Aurora Spine ZIP™ MIS Interspinous Fusion System and bone graft material in fusion in patients with chronic low back pain that present with degenerative disc disease with concurrent neurogenic claudication.

What is being tested

Sponsor: Pacific Research Institute · Participants: 100 · Started: Mar 19, 2021

Contact the study team

Official record on ClinicalTrials.gov — NCT05504499

Locations in the U.S.

FloridaThe Raso Pain Center, Jupiter
LouisianaKoga Neurosurgery, Slidell
MarylandNational Spine and Pain Centers, Oxon Hill
NevadaComprehensive & Interventional Pain Management, Henderson
Nevada Advanced Pain Specialists, Reno
Reno Tahoe Pain Associates, Reno
New JerseyThe Pain Management Center, Voorhees Township
OhioPremier Pain Treatment Institute, Loveland
PennsylvaniaCenter for Interventional Pain and Spine, Chadds Ford

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.